Dr George on the Efficacy and Safety of Subcutaneous Nivolumab in ccRCC
January 27th 2024
Saby George, MD, FACP, discusses the efficacy and safety of subcutaneous nivolumab in patients with clear cell renal cell carcinoma, according to findings from the phase 3 CheckMate 67T study.